tiprankstipranks
Aeterna Zentaris Finalizes Merger Details with Ceapro
Company Announcements

Aeterna Zentaris Finalizes Merger Details with Ceapro

Aeterna Zentaris Inc. (TSE:AEZS) has released an update.

Don't Miss our Black Friday Offers:

Aeterna Zentaris Inc. has completed a key share consolidation step ahead of its ‘merger of equals’ with Ceapro Inc., adjusting the share exchange ratio for Ceapro shareholders. Additionally, Aeterna’s shareholders as of May 29, 2024, will receive warrants for additional shares post-transaction, with automatic issuance via the DRS system. The completion of the merger is anticipated around June 3, 2024, as Aeterna continues to focus on developing pharmaceutical and diagnostic products for areas with significant unmet medical needs.

For further insights into TSE:AEZS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskCOSCIENS Biopharma Debuts New Name and Ticker
TheFlyAeterna Zentaris announces name change to Cosciens Biopharma
TipRanks Auto-Generated NewsdeskAeterna Zentaris Release: A Technical Glitch?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App